Enhancing Radiotherapy for Hypoxic Tumors: Integrative Strategies Using Bacteria and Nanoparticles
IET Nanobiotechnology · 2025
DOI: 10.1049/nbt2/2687439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IET Nanobiotechnology, 2025. Verfasst von Abolfazl Bemidinezhad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Tumor Hypoxia, Bacteria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer remains a major global health challenge, with radiotherapy (RT) being a cornerstone of treatment. However, the efficacy of RT is significantly hindered by hypoxic tumor microenvironments (TMEs) and nonselective toxicity to healthy tissues. Recent advancements in combining bacteria and nanoparticles have shown promise in addressing these limitations. Cyanobacteria, with their oxygen‐producing capabilities, alleviate tumor hypoxia, while anaerobic bacteria selectively target hypoxic regions. Nanoparticles complement these approaches by enhancing bacterial localization and amplifying radiosensitization through reactive oxygen species (ROS) generation and other synergistic therapies. Unlike previous reviews that have mainly focused on either bacterial therapy or nanoparticle‐assisted radiosensitization separately, this review provides a comparative and integrative perspective on their combined use, emphasizing the novelty of synergistic strategies. This review explores innovative bacterial–nanoparticle integrations, highlighting their roles in overcoming hypoxia and improving RT outcomes. The potential of these strategies to transform cancer treatment is discussed, alongside challenges and future directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pharmacy, College of Pharmacy, University of Kut, Al Kut, Wasit 52001, Iraq.
- Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Basic Medical Sciences, Termez University of Economics and Serviсe, Termez, Uzbekistan.
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Abolfazl Bemidinezhad, Abbas Al-Baghdadi, Anwer Alsarray, Yasaman Abolhassani, Yodgor Kenjayev, Fatemeh Gheybi
Zitieren
APA
Bemidinezhad, A., Al-Baghdadi, A., Alsarray, A., Abolhassani, Y., Kenjayev, Y., & Gheybi, F. (2025). Enhancing Radiotherapy for Hypoxic Tumors: Integrative Strategies Using Bacteria and Nanoparticles. IET Nanobiotechnology. https://doi.org/10.1049/nbt2/2687439
Vancouver
Bemidinezhad A, Al-Baghdadi A, Alsarray A, Abolhassani Y, Kenjayev Y, Gheybi F. Enhancing Radiotherapy for Hypoxic Tumors: Integrative Strategies Using Bacteria and Nanoparticles. IET Nanobiotechnology. 2025. doi:10.1049/nbt2/2687439
BibTeX
@article{Bemidinezhad2025,
author = {Bemidinezhad, Abolfazl and Al-Baghdadi, Abbas and Alsarray, Anwer and Abolhassani, Yasaman and Kenjayev, Yodgor and Gheybi, Fatemeh},
title = {Enhancing Radiotherapy for Hypoxic Tumors: Integrative Strategies Using Bacteria and Nanoparticles},
journal = {IET Nanobiotechnology},
year = {2025},
doi = {10.1049/nbt2/2687439}
}
EUVIMED